Date: May 7-9, 2024 Venue: Hilton Boston Back Bay, 40 Dalton Street, Boston, MA 02115, United States
Addressing key challenges such as sequence design, purity, stability, safety and translatability into clinical settings, this meeting is your only industry dedicated forum to delve into emerging technologies, latest data packages, and future directions to develop targeted, functional and efficacious first-in-class next generation RNA therapies in infectious diseases, oncology and beyond.
Boasting 20+ brand-new case studies, a fierce fireside chat on investment and collaboration opportunities and 3 interactive workshops this is your one-stop shop to hear first hand from the leading minds of the field such as from Replicate Bioscience, Laronde, Johnson & Johnson, Pfizer, Orbital Therapeutics and more to accelerate discovery, development and manufacturing of safe and effective next generation RNA therapeutics with significant advantages over the traditional therapies to treat previously “incurable” diseases with unmet needs.
What to Expect:
120+ attendees from biopharma and academia
22+ expert speakers
3 days of the hottest content on next generation RNA therapeutics
10+ hours of networking opportunities